The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder.
Rubio
Gabriel
G
Jiménez-Arriero
Miguel A
MA
Martínez-Gras
Isabel
I
Manzanares
Jorge
J
Palomo
Tomás
T
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D000077236:Topiramate
D000928:Antidepressive Agents; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose